Former U.S. President Donald Trump arrives to speak to the press after attending the civil fraud trial against the Trump Organization in New York State Supreme Court, in New York City on Jan. 11, 2024.

John Lamparski | AFP | Getty Images

The top court in New York State on Tuesday rejected an appeal by former President Donald Trump of a gag order imposed on him in his civil business fraud trial.

The New York Court of Appeals dismissed Trump’s challenge to the order “upon the ground that no substantial constitutional question is directly involved.”

The court also dismissed Trump’s motion to stay the gag order “as academic,” likely because the trial is over.

The gag order barred Trump from making public statements about the staff of Manhattan Supreme Court Judge Arthur Engoron.

Trump’s lawyers challenged the order as being unduly restrictive on his right to free speech.

Read more CNBC politics coverage

Engoron presided over Trump’s fraud trial and is expected to soon issue a verdict in the case.

The judge imposed the gag order on Trump after the former president repeatedly criticized Engoron’s principal law clerk during the trial.

Engoron, in October, fined Trump $5,000 for keeping online a post attacking the clerk after he issued the order.

New York Attorney General Letitia James sued Trump in the case for allegedly fraudulently manipulating the stated valuations of real estate assets, and his related financial statements, for financial gain.

James has asked Engoron to fine Trump $370 million, bar him from doing real estate business in the state for life and other sanctions.

Trump has denied any wrongdoing.

This is breaking news. Check back for updates.

Don’t miss these stories from CNBC PRO:

Post source: cnbc

You May Also Like

5 Reasons Why Tenant Screening is Important

Tenant screening is crucial in helping property managers and landlords learn more…

Mike Lynch Accused of Fraud in Autonomy Sale to HP

Mike Lynch, the founder of Autonomy, a software company that was sold…

Pfizer Reduces Stake in Haleon From 32% Down To 24%

Report Pfizer Reduces Stake in Haleon From 32% Down To 24% –…

Nationwide’s rush to buy Virgin Money risks member backlash, says ALEX BRUMMER

Nationwide’s aggressive pursuit of Virgin Money has sparked concerns among its members,…